JAK1 and acute lymphoblastic leukemia: In addition, somatic JAK1 mutations leading to a malignant phenotype such as T cell neoplasms, ALL, myeloproliferative neoplasm [264-266], AML, or other solid-organ cancers [248-250] have been described.